We are excited to announce that today, Singclean® for ophthalmic surgery is registered with the Directorate General of Drug Supplies and Drugs (DIGEMID) in Peru. It’s obvious that Singclean® for ophthalmic surgery are in high demand in Peru as we have received a lot of inquiries in a long time. So we made a great effort to support the registration process in order to provide an ideal viscoelastic solution for ophthalmic surgery for patients in Peru.
What is Singclean®?
Singclean® works as a surgical aid in ophthalmic anterior and posterior segment surgery including: Cataract extraction, Corneal transparent, Glaucoma, Filtering and Secondary lens implantation. It’s colourless and transparent gel, composed of highly purified sodium hyaluronate dissolved in buffered saline.
When should consider Singclean®?
As viscoelastic solution for ophthalmic surgery, hyaluronic acid can protect tissue out of mechanical damage from surgery device through shock absorption and cell layer lubrication. High maintain the good view for surgery operation.
Specification:
How to use Singclean®:
1. Cataract extraction surgery, IOL implantation: 0.2-0.75ml into anterior chamber, 0.1ml on the IOL spreading.
2. Cataract surgery: 0.1-0.5ml injection into anterior chamber.
3. IOL implantation: before implantation 0.1-0.5 injection into anterior chamber, 0.1ml on the IOL spreading.
4. Corneal transplant surgery: after removal of corneal, 0.1-0.5ml injection into anterior chamber, after transplant of corneal spreading around 0.1ml.
Certification:
CE/ISO13485/ISO9001/CFDA/SGS
-
singclean | 2019-08-27Singclean Medical to Host Its First International Aesthetic Leadership Forum at IMCAS China 2025Singclean Medical to Host Its First International Aesthetic Leadership Forum at IMCAS China 2025 Uniting Global Experts to Shape the Future of Scientific Aesthetics
-
singclean | 2019-08-27Singclean Medical to Showcase Breakthrough Aesthetic Solutions at IMCAS China 2025Shanghai, China – Singclean Medical is proud to announce its participation in IMCAS China 2025, one of Asia’s leading congresses for medical aesthetics, taking place from July 11 to 13 at the Kerry Hotel Pudong, Shanghai.
-
singclean | 2019-08-27Singclean Medical shines at HOSPITALAR 2025: Deeply cultivate the Latin American medical market with R&D and intelligent manufacturingSao Paulo, Brazil —— Singclean Medical, a world-leading absorbable biomaterial company, appeared at HOSPITALAR 2025 in June 2025, bringing four major product lines including regenerative medical beauty, orthopedics, ophthalmology and surgical hemostasis, to systematically demonstrate its global strength driven by the dual core of "R&D + automation" to the Latin American market. As a benchmark exhibition in the Latin American medical industry, this HOSPITALAR brings together top companies from around the world. Singclean Medica has become one of the core concerns of professional audiences on site with its CE/NMPA/ANVISA multi-certified product matrix and localized cooperation results.